GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tonix Pharmaceuticals Holding Corp (STU:TPM0) » Definitions » Float Percentage Of Total Shares Outstanding

Tonix Pharmaceuticals Holding (STU:TPM0) Float Percentage Of Total Shares Outstanding : 3,195.27% (As of Jun. 09, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Tonix Pharmaceuticals Holding Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Tonix Pharmaceuticals Holding's float shares is 95.54 Mil. Tonix Pharmaceuticals Holding's total shares outstanding is 2.99 Mil. Tonix Pharmaceuticals Holding's float percentage of total shares outstanding is 3,195.27%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Tonix Pharmaceuticals Holding's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Tonix Pharmaceuticals Holding's Institutional Ownership is 1.89%.


Tonix Pharmaceuticals Holding Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Tonix Pharmaceuticals Holding's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=95.54/2.99
=3,195.27%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tonix Pharmaceuticals Holding (STU:TPM0) Business Description

Industry
Traded in Other Exchanges
Address
26 Main Street, Suite 101, Chatham, NJ, USA, 07928
Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. its portfolio consists of the central nervous system, rare disease, immunology, and infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. CNS product candidate is TNX-102 SL, a proprietary sublingual tablet formulation of cyclobenzaprine (CBP) designed for bedtime administration.

Tonix Pharmaceuticals Holding (STU:TPM0) Headlines

No Headlines